Looking for volunteers
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
NCT07290621 · University of Chicago · Updated 6 Feb 2026
- What is being tested
- Toripalimab; Carboplatin; Paclitaxel
- For
- Oropharyngeal Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years and older. About 30 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started Feb 2026, ends Feb 2033. Registered 18 Dec 2025.
- Results
- None posted yet.
In the researchers' words
This is a single-center phase 2 study of to test how well the combination of toripalimab with chemotherapy followed by TORS or risk and response stratified de-escalated (chemo)radiotherapy works in patients with in HPV16+ locoregionally advanced oropharyngeal cancer (OPC).
Sites
- The University of Chicago Medicine Comprehensive Cancer CenterChicago, Illinois, United States